Antenatal Factors in the Development of Atopy and Asthma

Asthma: Critical Debates

Volumn , Issue , 2008, Pages 116-137

  Woodruff, Prescott G ^a,b   Prescott, Susan L ^c   Holt, Patrick G ^c,d   Fahy, John V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Asthma; Atopy; Environmental exposures; Hormonal changes; Immune systems

Indexed keywords

EID: 84948767925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470693889.ch8     Document Type: Chapter

References (161)

1. Wierenga EA, Snoek M, de Groot C et al. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 1990; 144: 4651-6.
2. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991; 12: 256-7.
3. Bray GW. The hereditary factor in hyperresponsiveness, anaphylaxis, and allergy. J Allergy 1931; 2: 205-24.
4. Happle R, Schnyder UW. Evidence for the Carter effect in atopy. Int 1982; 68: 90-2.
5. Aberg N. Familial occurrence of atopic disease: genetic versus environmental factors. Clin Exp Allergy 1993; 23:829-34.
6. Doull IJM. Maternal inheritance of atopy? Clin Exp Allergy 1996; 26: 613-15.
7. Johnson CC, Ownby DR, Peterson EL. Paternal history of atopic disease and concentration of cord IgE. Clin Exp Allergy 1996; 26: 624-9.
8. Michel FB, Bousquet J, Greillier P, Robinet-Levy M, Coulomb Y. Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic disease in early infancy. J Allergy Clin Immunol 1980; 65: 422-30.
9. Ruiz RGG, Kemeny DM, Price JF. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin Exp Allergy 1992; 22: 762-6.
10. Kuster W, Petersen M, Christophers E, Goos M, Sterry W. A family study of atopic dermatitis. Arch Dermatol Res 1990; 282: 98-102.
11. Halonen M, Stern D, Taussig L, Wright A, Ray CG, Martinez FD. The predictive relationship between serum IgE levels at birth and subsequent incidences of lower respiratory illnesses and eczema in infants. Am Rev Resp Dis 1992; 146:866-70.
12. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy 1993; 23: 504-11.
13. Kelly YJ, Brabin BJ, Milligan P, Heaf DP, Reid J, Pearson MG. Maternal asthma, premature birth, and the risk of respiratory morbidity in schoolchildren in Merseyside. Thorax 1995; 50: 525-30.
14. Holberg CJ, Morgan WJ, Wright AL, Martinez FD. Differences in familial segregation of FEVi between asthmatic and nonasthmatic families. Role of a maternal component. Am J Resp Crit Care Med 1998; 158: 162-9.
15. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996; 7: 109-16.
16. Van Duren-Schmidt K, Pichler J, Ebner C et al. Prenatal contact with inhalant allergens. Pediatr Res 1997; 41: 128-31.
17. Prescott SL, Macaubas C, Holt BJ et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses towards the Th-2 cytokine profile. J Immunol 1998; 160: 4730-7.
18. Bergmann RL, Edenharter G, Bergmann KE et al. Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 1997; 27: 752-60.
19. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1954; 7: 320.
20. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270:630-3.
21. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114-18.
22. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-6.
23. Jones C, Kilburn S, Warner J, Warner J. Intrauterine environment and fetal allergic sensitization. Clin Exp Allergy 1998; 28: 655-9.
24. Vince G, Shorter S, Starkey P et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 1992; 88: 174-80.
25. Yang Y, Yelvarthi KK, Chen HL, Pace JL, Terranova PF, Hunt JS. Molecular, biochemical, and functional characteristics of tumor necrosis factor produced by human placental cytotrophoblastic cells. J Immunol 1993; 150: 5614-24.
26. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184: 539-48.
27. Jones CA, Finlay-Jones JJ, Hart PH. Type I and type II cytokines in late gestational decidual tissue. Biol Reprod 1997; 57:303-11.
28. Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localisation of TGF-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46: 561-72.
29. Paulesu L, Romagnali R, Cintorino M, Ricci MG, Garotta G. First trimester trophoblast expresses both interferon-gamma and interferon-gamma receptor. J Reprod Immunol 1994; 27: 37-48.
30. Laham N, Brennecke SP, Bendzten K, Rice GE. Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. Eur J Endocrinol 1994; 131: 607-14.
31. Opsjln SL, Wathen NC, Tingulstad S et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169: 397-404.
32. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol 1996; 32:89-98.
33. Lang AK, Searle RF. The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 and beta 2 activity. Clin Exp Immunol 1994; 97: 158-63.
34. Warner JA, Jones CA, Williams TJ, Warner JO. Maternal programming in asthma and allergy. Clin Exp Allergy 1998; 28: 35-8.
35. Hansen LG, Halken S, Host A, Moller K, Osterballe O. Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE. IV. Pediatr Allergy Immunol 1993; 4: 34-40.
36. Croner S, Kjellman NI. Development of atopic disease in relation to family history and cord blood IgE levels. Ann Allergy 1990; 53: 167-71.
37. Magnusson CG. Cord IgE in relation to family history and as a predictor of atopic disease in early infancy. Allergy 1988; 43: 41-51.
38. Edenharter G, Bergmann RL, Bergmann KE et al. Cord blood-IgE as risk factor and predictor for atopic diseases. Clin Exp Allergy 1998; 28: 671-8.
39. Kondo N, Kobayashi Y, Shinoda S et al. Cord blood lymphocyte responses to food antigens for the prediction of allergic disorders. Arch Dis Child 1992; 67:1003-7.
40. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994; 24: 423-30.
41. Piccinni M-P, Mecacci F, Sampognaro S et al. Aeroallergen sensitization can occur during fetal life. Int 1993; 102: 301-3.
42. Holt PG, O'Keeffe PO, Holt BJ et al.T-cell 'priming' against environmental allergens in human neonates: sequential deletion of food antigen specificities during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr Allergy Immunol 1995; 6: 85-90.
43. Dahl GM, Telemo E, Westrom BR, Jacobsson I, Karlson BW. The passage of orally fed proteins from mother to foetus in the rat. Comp Biochem Physiol 1984; 77A: 199-201.
44. Szépfalusi Z, Loibichler C, Pichler J, Reisenberger K, Ebner C, Urbanek R. Direct evidence for transplacental allergen transfer. Pediatr Res 2000; 48:404-7.
45. Platts-Mills TA, Woodfolk JA. Cord blood proliferative responses to inhaled allergens: is there a phenomenon? J Allergy Clin Immunol 2000; 106:441-3.
46. Szépfalusi Z, Pichler J, Elsasser S et al. Transplacental priming of the human immune system with environmental allergens can occur early in gestation. J Allergy Clin Immunol 2000; 106: 530-6.
47. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353:196-200.
48. Holt PG, Clough JB, Holt BJ et al. Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992; 22:1093-9.
49. Rinas U, Horneff G, Wahn V. Interferon-7 production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr Allergy Immunol 1993; 4: 60-4.
50. Martinez F, Stern D, Wright A, Holberg C, Taussig L, Halonen M. Association of interleukin-2 and interferon-7 production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 1995; 96: 652-60.
51. Tang MLK, Kemp AS, Thorburn J, Hill D. Reduced interferon gamma secretion in neonates and subsequent atopy. Lancet 1994; 344: 983-5.
52. Liao SY, Liao TN, Chiang BL et al. Decreased production of IFN-7 and decreased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin Exp Allergy 1996; 26: 397-405.
53. Holt PG, Macaubas C. Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 1997; 9: 782-7.
54. Williams TJ, Jones CA, Miles EA, Warner JO, Warner JA. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol 2000; 105: 951-9.
55. Joshi P, Kakikios A, Shaw A, Issacs D. Cytokines and atopy in infancy [abstract]. ACIIntSuppl 2000; 2: 58.
56. Piccinni M-P, Beloni L, Giannarini L et al. Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. Eur J Immunol 1996; 26:2293-8.
57. Prescott SL, Macaubas C, Smallacombe T et al. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy 1998; 28: 39-44.
58. Yabuhara A, Macaubas C, Prescott SL et al. Th-2-polarised immunological memory to inhalant allergens in atopics is established during infancy and early childhood. Clin Exp Allergy 1997; 27: 1261-9.
59. Macaubas C, Sly PD, Burton P et al. Regulation of Th-cell responses to inhalant allergen during early childhood. Clin Exp Allergy 1999; 29: 1223-31.
60. Prescott SL, Jenmalm MC, Björksté B, Holt PG. Effects of maternal allergen-specific IgG in cord blood on early postnatal development of allergen-specific T-cell immunity. Allergy 2000; 55: 470-5.
61. Wilson CB, Westall J, Johnston L, Lewis DB, Dover SK, Apert AR. Decreased production of interferon gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 1986; 77: 860-7.
62. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest 1991; 87: 194-202.
63. Holt PG, Sly PD, Björksté B. Atopic versus infectious diseases in childhood: a question of balance? Ped Allergy Immunol 1997; 8: 56-8.
64. Romagnani S. Induction of Th1 and Th2 responses: a key role for the 'natural' immune response? Immunol Today 1992; 13: 379-81.
65. Manetti R, Gerosa F, Guidizi MG et al. Interleukin-12 induces stable priming for interferon-7 production during differentiation of human Th cells and transient interferon-7 production in established Th2 cell clones. J Exp Med 1994; 179: 1273-83.
66. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271: 1723-6.
67. Holt PG. Development of T-cell memory against inhalant allergens: risks for the future. Clin Exp Allergy 1999; 29: 8-13.
68. Holt PG. Environmental factors and primary T-cell sensitization to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995; 6: 1-10.
69. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FDA. Polymorphism in the 5 flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Resp Cell Mol Biol 1999; 20: 976-83.
70. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989; 299:1259-60.
71. Jones CA, Popplewell EJ, Diaper ND, Warner Jo. Failure to up-regulate sCD14 in early life is associated with the development of later atopy (abstract). ACI International 2000; (Suppl. 2): 59.
72. Strachan DP, Taylor EM, Carpenter RG. Family structure, neonatal infection, and hay fever in adolescence. Arch Dis Childhood 1996; 74: 422-6.
73. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995; 50: 1067-72.
74. Shaheen S. Changing patterns of childhood infection and the rise in allergic disease. Lancet 1995; 25:1034-7.
75. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-45.
76. Hanrahan JP, Halonen M. Antenatal interventions in childhood asthma. Eur Resp J 1998; 27 (Suppl): 46s-51s.
77. Aalberse RC, Nieuwenhuys EJ, Hey M, Stapel SO. 'Horoscope effect' not only for seasonal but also for nonseasonal allergens. Clin Exp Allergy 1992; 22:1003-6.
78. Lau S, Falkenhorst G, Weber W et al. High mite-allergen exposure increases the risk of sensitisation in atopic children and young adults. J Allergy Clin Immunol 1989; 84: 718-25.
79. Sporik R, Holgate ST, Platts-Mills T, Cogwell JJ. Exposure to house-dust mite allergen (Der p 1) and development of asthma in childhood. N Engl J Med 1990; 323: 502-7.
80. Björksté F, Suoniem I. Time and intensity of first pollen contacts and risk of subsequent pollen allergies. Acta Med Scand 1981; 209: 299-303.
81. Rugtveit J. Environmental factors in the first months of life and the possible relationship to later development of hypersensitivity. Allergy 1990; 45: 154-6.
82. Businco L, Cantani A, Farinella F, Businco E. Month of birth and grass pollen or mite sensitisation in children with respiratory allergy: a significant relationship. Clin Allergy 1988; 18: 269-74.
83. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995; 96: 1179-90.
84. Hesselmar B, Aberg N, Aberg B, Eriksson B, Björksté B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999; 29: 611-17.
85. Götzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. Br Med J 1998; 317: 1105-10.
86. Strachan DP. House dust mite allergen avoidance in asthma. Benefits unproved but not yet excluded. Br Med J 1998; 317: 1096-7.
87. Weiss ST. Diet as a risk factor for asthma. In: Holgate S. ed. CIBA Foundation Symposium, 1997. New York: Wiley, 1997; 244-57.
88. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70: S560-9.
89. Otto SJ, Houwelingen AC, Antal M et al. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr 1997; 51: 232-42.
90. Makrides M, Simmer K, Neumann M, Gibson R. Changes in the poly-unsaturated fatty acids of breast milk from mothers of full-term infants over 30 weeks of lactation. Am J Clin Nutr 1995; 61: 1231-3.
91. Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164: 137-40.
92. Hodge L, Salome CM, Hughes JM et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Resp J 1998; 11:361-5.
93. Peat JK, Salome CM, Woolcock AJ. Factors associated with bronchial hyper-responsiveness in Australian adults and children. Eur Resp J 1992; 5: 921-9.
94. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Resp J 1997; 10: 6-12.
95. Soyland E, Nenseter MS, Braathen L, Drevon CA. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro [published erratum appears in Eur J Clin Invest 1993; 23 (11): 761]. Eur J Clin Invest 1993; 23: 112-21.
96. Endres S, Meydani SN, Ghorbani R, Schindler R, Dinarello CA. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 1993; 54: 599-603.
97. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63: 116-22.
98. Khair-el-Din TA, Sicher SC, Vazquez MA, Wright WJ, Lu CY. Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma-induced Ia-expression by murine macrophages in vitro. J Immunol 1995; 154: 1296-306.
99. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 1993; 168: 915-22.
100. Hughes DA, Southon S, Pinder AC. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996; 126: 603-10.
101. Ross PS, Vos JG, Birnbaum LS, Osterhaus AD. PCBs are a health risk for humans and wildlife. Science 2000; 289:1878-9.
102. Van Loveren H, Ross PS, Osterhaus AD, Vos JG. Contaminant-induced immunosuppression and mass mortalities among harbor seals. Toxicol Lett 2000; 112-113: 319-24.
103. Ross PS, De Swart RL, Reijnders PJ, Van Loveren H, Vos JG, Osterhaus AD. Contaminant-related suppression of delayed-type hypersensitivity and antibody responses in harbor seals fed herring from the Baltic Sea. Environ Health Perspect 1995; 103: 162-7.
104. Weisglas-Kuperus N, Sas TC, Koopman-Esseboom C et al. Immunologic effects of background prenatal and postnatal exposure to dioxins and poly-chlorinated biphenyls in Dutch infants. Pediatr Res 1995; 38: 404-10.
105. Hilscherova K, Dusek L, Kannan K, Giesy JP, Holoubek I. Evaluation of cytotoxicity, dioxin-like activity and estrogenicity of complex environmental mixtures. Cent Eur J Public Health 2000; 8 (Suppl.): 28-9.
106. Reichertova E, Ciznar P, Prachar V, Palkovicova L, Veningerova M. Cord serum immunoglobulin E related to the environmental contamination of human placentas with organochlorine compounds. Environ Health Perspect 1999; 107: 895-9.
107. Stocks J. Lung function testing in infants. Pediatr Pulmonol. 1999; 18:14-20.
108. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112-17.
109. Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133-8.
110. Tager IB, Hanrahan JP, Tosteson TD et al. Lung function, pre-and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Resp Dis 1993; 147: 811-17.
111. Hanrahan JP, Tager IB, Segal MR et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Resp Dis 1992; 145: 1129-35.
112. Brown RW, Hanrahan JP, Castille RG, Tager IB. Effect of maternal smoking during pregnancy on passive respiratory mechanics in early infancy. Pediatr Pulmonol 1995; 19: 23-8.
113. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996; 348: 1060-4.
114. Carlsen KCL, Jaakkola JJK, Nafstad P, Carlsen K-H. In utero exposure to cigarette smoking influences lung function at birth. Eur Resp J 1997; 10: 1774-9.
115. Hoo A, Matthias H, Dezateux C, Costeloe K, Stocks J. Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Resp Crit Care Med 1998; 158: 700-5.
116. Yuskel BA, Greenough F, Griffin F, Nocolaides KH. Tidal breathing parameters in the first week of life and subsequent cough and wheeze. Thorax 1996; 51: 815-18.
117. Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Resp Crit Care Med 1999; 159: 403-10.
118. Ehrlich RI, Du Toit D, Jordaan E et al. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Resp Crit Care Med 1996; 154: 6812-6818.
119. Stein RT, Holberg CJ, Sherrill D et al. Influence on parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study. Am J Epidemiol 1999; 149: 1030-7.
120. Collins MH, Moessinger AC, Kleinerman J et al. Fetal lung hypoplasia associated with maternal smoking: a morphometric analysis. Pediatr Res 1985; 19: 408-12.
121. Bassi JA, Rosso P, Moessinger AC, Blanc WA, James LS. Fetal growth retardation due to maternal tobacco smoke exposure in the rat. Pediatr Res 1984; 18: 127-30.
122. Maritz GS. Effect of maternal nicotine exposure on growth in vivo of lung tissue of neonatal rats. Biol Neonate 1988; 53: 163-70.
123. Wang N, Chen M, Schraufnagel DE. The cumulative scanning electron microscopic changes in baby mouse lungs following prenatal and postnatal exposures to nicotine. J Pathol 1984; 144: 89-100.
124. Chen MF, Kimizuka G, Wang NS. Human fetal lung changes associated with maternal smoking during pregancy. Pediatr Pulmonol 1987; 3: 51-8.
125. Lieberman E, Torday J, Barbieri R, Cohen A, Vanukis HV, Weiss ST. Association of intrauterine cigarette smoke exposure with indices of fetal lung maturation. Obstet Gynecol 1992; 79: 564-70.
126. Strachan DP, Cook DG. Health effects of passive smoking: parental smoking and allergic sensitisation in children. Thorax 1998; 53: 117-23.
127. Kjellman N-IM. Effect of parental smoking on IgE levels in children [letter]. Lancet 1981; i: 993-4.
128. El-Nawawy A, Soliman AT, El-Azzouni O, El-Sayed A, Demian S, El-Sayed M. Effect of passive smoking on frequency of respiratory illnesses and serum immunoglobulin-E (IgE) and interleukin-4 (IL-4) concentration on exposed children. J Trop Pediatr 1996; 42: 166-9.
129. Ronchetti R, Macri F, Ciofetta G et al. Increased serum IgE and increased prevalence of eosinophilia in 9-year-old children of smoking parents. J Allergy Clin Immunol 1990; 86: 400-7.
130. Ronchetti R, Bonci E, Cutrera R et al. Enhanced allergic sensitisation related to parental smoking. Arch Dis Childhood 1992; 67: 496-500.
131. Weiss ST, Tager IB, Munoz A, Speizer FE. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial hyperresponsiveness. Am Rev Resp Dis 1985; 131: 573-8.
132. Geller-Bernstein G, Kennett R, Weisglass L, Tsur S, Lahav M, Levin S. Atopic babies with wheezy bronchitis. Follow-up study relating prognosis to sequential IgE values, type of early infant feeding, exposure to parental smoking and incidence of lower respiratory tract infections. Allergy 1987; 42: 85-91.
133. Cogswell JJ, Mitchell EB, Alexander J. Parental smoking, breast feeding, and respiratory infection in development of allergic diseases. Arch Dis Childhood 1987; 62: 338-44.
134. Ownby DR, McCullough J. Passive exposure to cigarette smoke does not increase allergic sensitization in children. J Allergy Clin Immunol 1988; 82: 634-8.
135. Henderson FW, Henry MM, Ivins SS et al. Correlates of recurrent wheezing in school-age children. The Physicians Raleigh Pediatric Associates. Am J Resp Crit Care Med 1995; 151: 1786-93.
136. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic disorders in infancy. J Allergy Clin Immunol 1992; 90: 235-41.
137. Soyseth V, Konegrud J, Boe J. Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995; 107: 389-94.
138. Kuehr J, Frischer T, Karmaus W et al. Early childhood risk factors for sensitization at school age. JAllergy Clin Immunol 1992; 90: 358-63.
139. Zetterstrom O, Osterman K, Machado L, Johansson SGO. Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J 1981; 283: 1215-17.
140. McSharry C, Wilkinson PC. Cigarette smoking and the antibody response to inhaled antigens. Immunol Today 1986; 7: 98.
141. Lewis S, Richards D, Bynner J, Butler N, Britton J. Prospective study of risk factors for early and persistent wheezing in childhood. Eur Resp J 1995; 8: 349-56.
142. Seidman DS. Is low birth weight a risk factor for asthma during adolescence? Arch Dis Child 1991; 66: 583-7.
143. Svanes C, Omenaas E, Heuch JM, Irgens LM, Gulsvik A. Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. Eur Resp J 1998; 12:1366-70.
144. Barker DJ. The fetal and infant origins of adult disease. Br Med J 1990; 301: 1111.
145. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. Br Med J 1991; 303: 671-5.
146. Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and intrauterine growth retardation on respiratory health and lung function in childhood. Br Med J 1993; 306: 817-20.
147. Galdes-Sebaldt M, Sheller JR, Grogaard J, Stahlman M. Prematurity is associated with abnormal airway function in childhood. Pediatr Pulmonol 1989; 7:259-64.
148. von Mutius E, Nicolai T, Martinez FD. Prematurity as a risk factor for asthma in preadolescent children. J Pediatr 1993; 123: 223-9.
149. Infante-Rivard C. Young maternal age: a risk factor for childhood asthma? Epidemiology 1995; 6: 178-80.
150. Schwartz J, Gold D, Dockery DW, Weiss ST, Speizer FE. Predictors of asthma and persistent wheeze in a national sample of children in the United States. Am Rev Resp Dis 1990; 142: 555-62.
151. Martinez FD, Wright AL, Holberg CJ, Morgan WJ, Taussig LM. Maternal age as a risk factor for wheezing lower respiratory illnesses in the first year of life. Am J Epidemiol 1992; 136: 1258-68.
152. Xu B, Pekkanen J, Jearvelin MR, Olsen P, Hartikainen AL. Maternal infections in pregnancy and the development of asthma among offspring. Int 1999; 28: 723-7.
153. Chandra RK, Puri S, Suraiya C, Cheema PS. Influence of maternal food antigen avoidance during pregnancy and lactation on incidence of atopic eczema in infants. Clin Allergy 1986; 16:563-9.
154. Falth-Magnusson K, Kjellman NIM. Development of atopic disease in babies whose mothers were receiving exclusion diet during pregnancy-a randomized study. J Allergy Clin Immunol 1987; 80:869-75.
155. Falth-Magnusson K, Kjellman NIM. Allergy prevention by maternal elimination diet during late pregnancy- a 5 year follow-up of a randomized study. J Allergy Clin Immunol 1992; 89:709-13.
156. Zeiger RS, Heller S, Mellon MH et al. Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study. J Allergy Clin Immunol 1989; 84:72-89.
157. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases in early childhood. Lancet 1994; 344: 456-8.
158. Holt PG, Sly PD. Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax 1997; 52: 1-4.
159. Strannegârd I-L, Larsson L-O, Wennergren G, Strannegàird O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998; 53: 249-54.
160. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350: 400-3.
161. Aaby P, Shaheen SO, Heyes CB et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000; 30: 644-50.